Status:
COMPLETED
Alexithymia Frequency and Interhemispheric Transfer in Patients With a First Demyelinating Event
Lead Sponsor:
University Hospital, Lille
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Brief Summary
Prevalence of alexithymia in multiple sclerosis (MS) is closed to 50% but is unknown in clinically isolated syndrome (CIS).The present study sought to characterize alexithymia in CIS patients and his ...
Detailed Description
The aim to recruit 40 CIS patients with at least two subclinical lesions on brain MRI. Patients are tested only one month at least after steroids intake and after 6 weeks at least after any relapse. T...
Eligibility Criteria
Inclusion
- right-handed patient
- at least 1 month after steroid intake
- without severe neurological impairment
- without psychiatric disorder
Exclusion
- patients with steroids in the last month
- patients with psychotropic drugs started in the last month
- patients with immunotherapies
- patients having contra indications for MRI
- pregnancy or breast feeding
Key Trial Info
Start Date :
May 2 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT03796247
Start Date
May 2 2011
End Date
May 1 2016
Last Update
January 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Roger Salengro, CHRU de Lille
Lille, France